en
Scientific article
English

Brain development of the preterm neonate after neonatal hydrocortisone treatment for chronic lung disease

Published inPediatric research, vol. 66, no. 5, p. 555-559
Publication date2009
Abstract

Previous studies reported impaired cerebral cortical gray matter (CGM) development and neurodevelopmental impairment after neonatal dexamethasone treatment for chronic lung disease (CLD) in preterm newborns. No long-term effects on neurocognitive outcome have yet been shown for hydrocortisone treatment. A prospective study was performed to evaluate the brain growth at term in preterm infants who did receive neonatal hydrocortisone for CLD. Thirty-eight preterm infants (n = 19 hydrocortisone, n = 19 controls) were matched for gestational age at birth. Gestational age and birth weight were 27.0+/- 1.4 versus 27.6+/- 1.1 wk (p = ns) and 826+/- 173 versus 1017+/- 202 g, respectively (p < 0.05). Infants were studied at term equivalent age. Hydrocortisone was started with a dose of 5 mg/kg/d for 1 wk, followed by a tapering course over 3 wk. A 3D-MRI technique was used to quantify cerebral tissue volumes: CGM, basal ganglia/thalami, unmyelinated white matter, myelinated white matter, cerebellum, and cerebrospinal fluid. Infants who were treated with hydrocortisone had more severe respiratory distress. There were no differences in cerebral tissue volumes between the two groups at term equivalent age. In conclusion, no effect on brain growth, measured at term equivalent age, was shown after treatment with hydrocortisone for CLD.

Keywords
  • Age Factors
  • Birth Weight
  • Brain/*drug effects/*metabolism/pathology
  • Chronic Disease
  • Gestational Age
  • Humans
  • Hydrocortisone/*adverse effects/pharmacology
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases/drug therapy
  • Lung Diseases/*drug therapy
  • Magnetic Resonance Imaging/methods
  • Prospective Studies
Citation (ISO format)
BENDERS, Manon J N. L. et al. Brain development of the preterm neonate after neonatal hydrocortisone treatment for chronic lung disease. In: Pediatric research, 2009, vol. 66, n° 5, p. 555–559. doi: 10.1203/PDR.0b013e3181b3aec5
Main files (1)
Article
accessLevelRestricted
Identifiers
ISSN of the journal0031-3998
468views
0downloads

Technical informations

Creation04/23/2012 1:22:52 PM
First validation04/23/2012 1:22:52 PM
Update time03/14/2023 5:24:01 PM
Status update03/14/2023 5:24:01 PM
Last indexation02/12/2024 7:55:42 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack